dc.relation.references | AMORIM, A. G.; AMORIM, R. F. B.; FREITAS, R. A. Estudo epidemiológico do carcinoma epidermóide oral: análise de 85 casos. Odontologia Clínico-Científica, v.1, n. 1, p. 41- 45, 2002.
ANNEROTH, G.; BATSAKIS, J. G.; LUNA, M. Malignancy grading of squamous cell carcinoma in the floor of the mouth related to clinical evaluation. Scandinavian Journal of Dental Research, v. 94, n. 4, p. 347-358, 1986.
ANNEROTH, G.; BATSAKIS, J. G.; LUNA, M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scandinavian Journal of Dental Research, v. 95, n. 3, p. 229-249, 1987.
ANNEROTH, G.; HASSEN, L. S. A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scandinavian Journal of Dental Research, v. 92, n.5, p. 448-468, 1984.
BACHMANN, I. M., et al. Importance of p-cadherin, β-catenin, and Wnt5a-Frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clinical Cancer Research, v. 11, n. 24, p. 8606-8614, 2005.
BÁNKFALVI, A., et al. Deranged expression of the E-cadherin/β-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. Journal of Oral Pathology & Medicine, v. 31, n.8, p. 450-457, 2002.
BARTH, A. I.; NÄTHKE, I. S.; NELSON, W. J. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Current Opinion in Cell Biology, v. 9, n. 5, p. 683-690, 1997.
BEAVON, I. R. G. The E-cadherin-catenin complex in tumor metastasis: structure, function and regulation. European Journal of Cancer, v. 36, n. 13, p. 1607-1620, 2000.
BEHRENS, J. Cadherins and catenins: Role in signal transduction and tumor progression. Cancer and Metastasis Reviews, v. 18, n.1, p. 15-30, 1999.
BEHRENS, J.; LUSTIG, B. The Wnt connection to tumorigenesis. The International Journal of Developmental Biology, v. 48, n. 5-6, p. 477-487, 2004.
BELL, R. B., et al. Tongue cancer: is there a difference in survival compared with other subsites in the oral cavity? Journal of Oral Maxillofacial and Surgery, v. 65, n.2, p. 229-236, 2007.
BEN-ZE´EV, A.; GEIGER, B. Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Current Opinion in Cell Biology, v. 10, n. 5, p. 629-639, 1998.
BEN-ZE´EV, A.; SHTUTMAN, M.; ZHURINSKY, J. The integration of cell adhesion with gene expression: the role of beta-catenin. Experimental Cell Research, v. 261, n. 1, p. 75-82, 2000.
BLANC, E., et al. Wnt-5a gene expression in malignant human neuroblasts. Cancer Letters, v. 228, n. 1-2, p. 117-123, 2005.
BRODERS, A. C. The microscopic grading of cancer. The Surgical Clinics of North America, v. 21, p. 947-962, 1941.
BRYJA, V.; et al. Wnt-5a induces disheveled phosphorylation and dopaminergic differentiation via a CK1- dependent mechanism. Journal of Cell Science, v. 120, n. 4, p. 586-595, 2007.
BRYNE, M., et al. Reproducibility of two malignancy grading systems with reportedly prognostic value for oral cancer patients. Journal of Oral pathology & Medicine, v. 20, n. 8, p. 369-372, 1991.
CADIGAN, K. M.; NUSSE, R. Wnt signaling: a common theme in animal development. Genes & development, v.11, n. 24, p. 3286-3305, 1997.
CARVALHO, M. B., et al. Características clínico-epidemiológicas do carcinoma de cavidade oral no sexo feminino. Revista da Associação Médica Brasileira, v. 47, n. 3, p.208-214, 2001.
CASTRO, J., et al. β-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. Virchows Archiv, v. 437, n.6, p. 599-604, 2000.
CHANDU, A.; ADAMS, G.; SMITH, A. C. H. Factors affecting survival in patients with oral cancer: an Australian perspective. International Journal of Oral and Maxillofacial Surgery, v. 34, n.5, p. 514-520, 2005.
CHEN, R. H.; DING, W. V.; McCORMICK, F. Wnt signaling to β-catenin involves two interactive components. The Journal of Biological Chemistry, v. 275, n. 23, p. 17894-17899, 2000.
CHENG, C., et al. Wnt 5a-mediated non-canonical Wnt signaling regulates human endothelial cell proliferation and migration. Biochemical and Biophysical Research Communications, v. 365, n.2, p. 285-290, 2008.
CHOI, Y. S., et al. Prognostic significance of E-cadherin and β-catenin in resected stage I non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery, v. 24, n.3, p. 441-449, 2003.
CHOW, V., et al. A comparative study of the clinicopatological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinoma. Journal of Cancer Research and Clinical Oncology, v. 127, n. 1, p. 59-63, 2001.
CLARK, C. C., et al. Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21. Genomics, v.18, n. 2, p. 249-260, 1993.
CONACCI – SORRELL, M.; ZHURINSKY, J.; BEN – ZE´EV, A. The cadherin-catenin adhesion system in signaling and cancer. The Journal of Clinical Investigation, v. 109, n. 8, p. 987-991, 2002.
CONG, F., et al. Requirement for a nuclear function of β-catenin in Wnt signaling. Molecular and Cellular Biology, v. 23, n. 23, p. 8462-8470, 2003.
CONG, F.; SCHWEISER, L.; VARMUS, H. Wnt signals across the plasma membrane to activate the β-catenin by forming oligomers containing its receptor, frizzled and LRP. Development, v. 131, n.20, p. 5103-5115, 2004.
COSTA, A. L. L., et al. Correlation between TNM classification and malignancy histological feature of oral squamous cell carcinoma. Revista Brasileira de Otorrinolaringologia, v. 71, n. 2, p. 181-187, 2005.
CUI, J., et al. Mutation and overexpression of the β-catenin gene may play an important role in primary hepatocellular carcinoma among chinese people. Journal of Cancer Research and Clinical Oncology, v. 127, n. 9, p. 577-581, 2001.
DAA, T., et al. Mutations in components of the Wnt signaling pathway in adenoid cystic carcinoma. Modern Pathology : An Official Journal of The United States and Canadian Academy of Pathology, Inc, v.17, n. 12, p. 1475-1482, 2004.
DANIELSON, K. G., et al. Characterization of the complete genomic structure of the human WNT-5A gene, functional analysis of its promoter, chromosomal mapping, and expression in early human embryogenesis. The Journal of Biological Chemistry, v. 270, n. 52, p. 31225-31234, 1995.
De AGUIAR, A. F. Jr.; KOWALSKI, L. P.; De ALMEIDA, O. P. Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncology, v. 43, n. 6, p. 593-601, 2007.
De VISSHER, J. G. A. M., et al. Epidemiology of câncer of the lip in the Netherlands. Oral Oncology, v. 34, n. 5, p. 421-426, 1998.
DEDIVITIS, R. A. et al. Características clínico-epidemiológicas no carcinoma espinocelular de boca e orofaringe. Revista Brasileira de Otorrinolaringologia, v. 70, n. 1, p. 35-40, 2004.
DURAZZO, M. D., et al. Clinical and epidemiological features of oral cancer in a medical school teaching hospital from 1994 to 2002: Increasing incidence in women, predominance of advanced local disease, and low incidence of neck metastases. Clinics, v. 60, n. 4, p. 293-298, 2005.
ENNEROTH, C. M.; HJERTMAN, L.; MORBERGER, G. Squamous cell carcinomas of the palate. Acta Oto-laryngologica, v. 73, n. 5, p. 418-427, 1972.
FILLIES, T., et al. Catenin expression in T1/2 carcinomas of the floor of the mouth. International Journal of Oral and Maxillofacial Surgery, v. 34, n.8, p. 907-911, 2005.
GAO, S., et al. Cytoplasmic expression of E-cadherin and β-catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas. Journal of Oral Pathology & Medicine, v. 34, n.2, p. 116-119, 2005.
GERVÁSIO, O. L. A. S., et al. Oral squamous cell carcinoma: a retrospective study of 740 cases in a brazilian population. Brazilian Dental Journal, v. 12, n. 1, p. 57-61, 2001.
GÓES, Caroline. Perfil epidemiológico do paciente com câncer de cabeça e pescoço atendido no setor de cabeça e pescoço no setor de odontologia do Hospital Aristides Maltez no ano de 2006. 2007. 80 f. Dissertação (Mestrado em Clínica Odontológica) - Faculdade de Odontologia, Universidade Federal da Bahia, Salvador.
GONZALES-MOLES, M. A., et al. Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity. Acta Stomatologica Belgica, v. 93, n. 4, p. 159-165, 1996.
GONZÁLEZ-SANCHO, J. M., et al. Wnt proteins induce dishevelled phosphorylation via an LRP5/6 – independent mechanism, irrespective of their ability to stabilize β-catenin. Molecular and Cellular Biology, v. 24, n. 11, p. 4757-4768, 2004.
GORDON, M. D.; NUSSE, R. Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. Journal of Biology Chemistry, v. 281, n. 32, p. 22429-22433, 2006.
GUERRA, E. N. S. et al. Expressão imunohistoquímica da ciclina D1 e do p 16 em carcinoma epidermóide de boca: correlação com sistema TNM e localização. Revista Brasileira de Cancerologia, v. 51, n. 1, p. 31-37, 2005.
HINOI, T., et al. Complex formation of Adenomatous Polyposis Coli gene product and Axin facilitates glycogen synthase kinase-3β-dependent phosphorrylation of β-catenin and down-regulates β-catenin. The Journal of Biology Chemistry, v. 275, n. 44, p. 34399-34406, 2000.
HIROHASHI, S.; KANAI, Y. Cell adhesion system and human cancer morphogenesis. Cancer Science, v. 94, n. 7, p. 575-581, 2003.
HOWNG, S. L., et al. Differential expression of Wnt genes, β-catenin and E-cadherin in human brain tumors. Cancer Letters, v. 183, n.1, p. 95-101, 2002.
HUANG, C. L., et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor – an expression in non-small-cell lung cancer. Journal of Clinical Oncology, v. 23, n. 34, p. 8765 – 8773, 2005.
INCA – Instituto Nacional do Câncer. Ministério da Saúde (BRASIL). Secretaria de Atenção à Saúde. Instituto Nacional do Câncer. Coordenação de Prevenção e Vigilância. Estimativa 2006: Incidência de Câncer no Brasil: Rio de Janeiro, 2005.
INCA – Instituto Nacional do Câncer. Ministério da Saúde (BRASIL). Secretaria de Atenção à Saúde. Instituto Nacional do Câncer. Coordenação de Prevenção e Vigilância. Estimativa 2008/2009: Incidência de Câncer no Brasil: Rio de Janeiro, 2007.
ISHIDA, K., et al. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Molecular Cancer, v. 62, n. 6, p. 1-7, 2007.
ISHIZAKI, Y., et al. Immunohistochemical analysis and mutacional analyses of β-catenin, Axin family and APC genes in hepatocelular carcinomas. International Journal of Oncology, v. 24, n.5, p. 1077-1083, 2004.
IWAI, S., et al. Mutations of the APC, beta-catenin and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology, v.131, n.12, p. 773-782, 2005.
IYPE, E. M., et al. Squamous cell cancer of the buccal mucosa in Young adults. British Journal of Oral and Maxillofacial Surgery, v. 42, n.3, p. 185-189, 2004.
JAKOBSSON, P.A., et al. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiologica: Therapy, Physics, Biology, v. 12, n. 1, p. 1-8, 1973.
JANKOWSKI, J. A., et al. Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Journal of Clinical Pathology, v. 50, n.6, p. 289-290, 1997.
JÖNSSON, M., et al. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Research, v. 62, n. 2, p. 409-416, 2002.
KADEMANI, D., et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. Journal of Oral and Maxillofacial Surgery, v. 63, n. 11, p. 1599-1605, 2005.
KIKUCHI, A.; YAMAMOTO, H. Tumor formation due to abnormalities in the β-catenin-independent pathway of Wnt signaling. Cancer Science, v. 99, n. 2, p. 202-208, 2008.
KIKUCHI, A.; YAMAMOTO, H.; KISHIDA, S. Multiplicity of the interactions of Wnt proteins and their receptors. Cellular Signaling, v. 19, n. 4, p. 659-671, 2007.
KIM, K. M., et al. Epidemiologic survey of head and neck cancers in Korea. Journal of Korean Medical Science, v. 18, p. 80-87, 2003.
KISHIDA, S., et al. Axin, a negative regulator of the Wnt signaling pathway, directly interacts with Adenomatous Polyposis Coli and regulates the stabilization of β-catenin. The Journal of Biological Chemistry, v. 273, n. 18, p. 10823 -10826, 1998.
KOHN, A. D.; MOON, R. T. Wnt and calcium signaling: β-catenin-independent pathways. Cell Calcium, v. 38, n. 3-4, p. 439 – 446, 2005.
KUDO, Y., et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membraneous beta-catenin. Clinical Cancer Research, v. 10, n. 16, p. 5455-5463, 2004.
KÜHL, M., et al. The Wnt/Ca+2 pathway a new vertebrate Wnt signaling pathway takes shape. Trends in Genetics : TIG, v. 16, n. 7, p. 279-283, 2000.
KURAYOSHI, M., et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Research, v. 66, n. 21, p. 10439-10448, 2006.
KURTZ, A. K., et al. Decreased E-cadherin but not β-catenina expression is associated with vascular invasion and decreased survival in head and neck squamous cell carcinomas. Otolarynology – Head and Neck Surgery, v. 134, n. 1, p142-146, 2006.
LEE, C. M., et al. β-catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecologic Oncology, v. 88, n. 3, p. 363-368, 2003.
LIN, Y. C., et al. Prognostic and clinicopathological features of E-cadherins, α-catenin, β-catenin, γ-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World Journal of Gastroenterology: WJG, v. 10, n. 22, p. 3235-3239, 2004.
LIU, G.; BAFICO, A.; AARONSON, S. A. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Molecular and Celular Biology, v. 25, n. 9, p. 3475-3482, 2005.
LLEWELLYN, C. D.; JOHNSON, N. W.; WARNAKULASURIYA, K. A. A. S. Risck factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case–control study in Southern England. Journal of Oral Pathology & Medicine, v. 33, n. 9, p. 525-532, 2004.
LOGAN, C. Y.; NUSSE, R. The Wnt signaling pathway in development and desease. Annual Review of Cell Biology, v. 20, p. 781-810, 2004.
LOPEZ-GONZALEZ, J. S., et al. Localization and level of expression of β-catenin in human laryngeal squamous cell carcinoma. Otolaryngology - Head and Neck Surgery, v.130, n. 1, p. 89-93, 2004.
LUSTIG, B.; BEHERNS, J. The Wnt signaling pathway and its role in tumor development. Journal of Cancer Research and Clinical Oncology, v.129, n. 4, p. 199-221, 2003.
MAHOMED, F; ALTINI, M, MEER, S. Altered E-cadherin/β-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Diseases, v.13, n. 4, p. 386-392, 2007.
MENZIN, J.; LINES, L. M.; MANNING, L. N. The economics of squamous cell carcinoma of the head and neck. Current Opinion in Otolaryngology & Head and Neck Surgery, v. 15, n. 2, p. 68-73, 2007.
MIGUEL, M. C. C.; AMORIM, R. F. B. Multifuncionalidade da beta-catenina e suas implicações na patologia. Revista Brasileira de Patologia Oral, v. 3, n. 2, p. 57-61, 2004.
MILLER, J. R. The Wnts. Genome Biology, v.3, n.1, 2001.
MIZUSHIMA, T., et al. Wnt-1 but not epidermal growth factor induces β-catenina/ T-cell factor-dependent Transcription in Esophageal cancer cells. Cancer Research, v. 62, n. 1, p. 227-282, 2002.
NAGAFUCHI, A. Molecular architecture of adherens junctions. Current Opinion in Cell Biology, v. 13, n. 5, p. 600-603, 2001.
NELSON, W. J.; NUSSE, R. Convergence of Wnt, β-catenin, and cadherin pathways. Science, v. 303, n. 5663, p. 1483-1487, 2004.
NICHOLS, A. C.; BHATTACHARYYA, N. Racial differences in stages and survival in head and neck squamous cell carcinoma. The laryngoscope, v. 117, n. 5, p. 770-775, 2007.
NINOMIYA, I., et al. Alteration of β-catenina expression in esophageal squamous cell carcinoma. International Journal of Cancer, v. 85, n. 6, p. 757-761, 2000.
NUSSE, R. Wnt signaling in disease and in development. Cell Research, v.15, n.1, p. 28-32, 2005.
PERUSSI, M. R., et al. Carcinoma epidermóide da boca em idosos de São Paulo. Revista da Associação Médica Brasileira,v. 48, n. 4, p. 341-344, 2002.
PIRINEN, R. T., et al. Reduced expression of α-catenin, β-catenin , and γ-catenin is associated with high cell proliferation in non-small cell lung cancer. Journal of Clinical Pathology, v. 54, n. 5, p. 391-395, 2001.
POLAKIS, P. Wnt signaling and cancer. Genes & Development, v. 14, n. 15, p. 1837-1851, 2000.
PRUNIER, C; HOCEVAR, B. A.; HOWE, P. H. Wnt signaling: Physiology and Pathology. Growth Factors, v. 22, n. 3, p. 141-150, 2004.
PUKROP, T.; BINDER, C. The complex pathways of Wnt 5a in cancer progression. Journal of Molecular Medicine, v. 86, n. 3, p. 259 – 66, 2008.
RIPPEY, J. J. Why classify basal cell carcinomas? Histopathology, v.32, n.5, p. 393-398, 1998.
RODRIGUEZ-PINILLA, M., et al. Β-catenin, Nf- ЌB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters. Cancer Letters, v. 230, n. 1, p. 141-148, 2005.
ROMAN-GOMEZ, J., et al. WNT5A, a putative tumor suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. European Journal of Cancer, v. 43, n. 18, p. 2736-2746, 2007.
SAEGUSA, M., et al. β-catenin simultaneously induces activation of p 53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. American Journal of Pathology, v. 164, n. 5, p. 1739-1749, 2004.
SCULLY, C.; BAGAN, J. V. Recent advances in oral oncology. Oral Oncology, v. 43, n. 2, p. 107-115, 2007.
SHTUTMAN, M., et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proceedings of the National Academy of Sciences of the United States of America, v. 96, n. 10, p. 5522-5527, 1999.
SMITH, M. E.; PIGNATELLI, M. The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology, v. 31, n. 2, p. 107-111, 1997.
TAKI, M., et al. Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Science, v. 94, n. 7, p. 593-597, 2003.
UEDA, G., et al. Aberrant expression of β and γ-catenin is an independent prognostic marker in oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, v. 35, n. 4, p. 356-361, 2006.
URAGUCHI, M., et al. Activation of Wnt family expression and signaling in squamous cell carcinomas of the oral cavity. Journal of Dental Researsh, v. 83, n. 4, p. 327-332, 2004.
VEECK, E. B., et al. Estudo epidemiológico dos carcinomas espinocelulares na cavidade bucal. Odonto Ciência, v. 7, n.14, 1992.
VENESS, M. J., et al. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the westmead Hospital experience, 1980 – 1997. Australian Radiology, v. 45, n. 2, p. 195-199, 2001.
WANG, L., et al. Altered expression of desmocollin 3, desmoglein 3 and β-catenin oral squamous cell carcinoma: Correlation with lymph node metastasis and cell proliferation. Virchows Archiv, v. 451, n. 5, p. 959-966, 2007.
WIJNHOVEN, B. P. L.; DINJENS, W. N. M.; PIGNATELLI, M. E. Cadherin-catenin cell-cell adhesion complex and human cancer. The British Journal of Surgery, v. 87, n. 8, p. 992-1005, 2000.
WILLERT, K.; NUSSE, R. β-catenin: a key mediator of Wnt signaling. Current Opinion in Genetics & Development, v. 8, n. 1, p. 95-102, 1998.
WILLIAMS, H. K. Molecular pathogenesis of oral squamous carcinoma. Journal of Clinical Pathology, v. 53, n. 4, p. 165-172, 2000.
WILLIAMS, H. K., et al. Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. Journal of Oral Pathology & Medicine, v. 27, n. 7, p. 308-317, 1998.
WORLD HEALTH ORGANIZATION (WHO). Pathology and Genetics of Head and Neack Tumors. World Health Organization Classification of Tumors. IARC Press: Lyon 2005.
YANG, F., et al. Wnt/β-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cellular Signaling, v. 18, n. 5, p. 679-687, 2006.
YEH, K. T., et al. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. International Journal of Oncology, v. 23, n. 4, p. 1001-1007, 2003.
YU, Z., et al. β-catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Clinical Cancer Research, v. 11, n. 7, p. 2471-2477, 2005.
ZHANG, W. M., et al. Effect of Wnt -1 on β-catenin expression and its relation to Ki-67 and tumor differenciation in oral squamous cell carcinoma. Oncology Reports, v. 13, n. 6, p. 1095-1099, 2005.
ZHURINSKY, J.; SHTUTMAN, M.; BEN- ZE´EV, A. Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. Journal of Cell Science, v. 113, n. 18, p. 3127-3129, 2000. | pt_BR |